Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05350514 · ClinicalTrials.gov registry record
Preclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept Study
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 14
- Enrollment target
NCT05350514 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 14 participants.
The verdict
NCT05350514 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The goal of the study is to characterize preclinical Alzheimer's Disease and related dementias (AD/ADRD) neuropathology in a selected group of young adults with youth-onset diabetes, and an age-similar group of young adults without diabetes.
Interventions
- DRUG PI-2620 tracer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-07-19 |
| Est. Completion | 2023-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05350514
The ClinicalTrials.gov registry entry for NCT05350514 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PI-2620 tracer is the first listed.
NCT05350514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05350514 about?
NCT05350514 is a clinical study titled "Preclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept Study". The goal of the study is to characterize preclinical Alzheimer's Disease and related dementias (AD/ADRD) neuropathology in a selected group of young adults with youth-onset diabetes, and an age-similar group of young adults without diabetes.
What is the current status of trial NCT05350514?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2022-07-19. Estimated completion is 2023-05-31.
What interventions are being tested in trial NCT05350514?
The interventions under investigation include: PI-2620 tracer (DRUG).
Who is sponsoring clinical trial NCT05350514?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.